BNP Paribas Financial Markets
FBLG icon

BNP Paribas Financial Markets’s FibroBiologics FBLG Stock Holding History

BNP Paribas Financial Markets’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87 Buy
66
+1
+2% +$6 ﹤0.01% 5691
2025
Q4 		$294 Hold
65
– – ﹤0.01% 5530
2025
Q3 		$713 Sell
65
-21
-24% -$251 ﹤0.01% 5278
2025
Q2 		$1.07K Sell
86
-34
-28% -$613 ﹤0.01% 5138
2025
Q1 		$2.15K Sell
120
-65
-35% -$1.86K ﹤0.01% 4975
2024
Q4 		$7.39K Sell
185
-86
-32% -$4.62K ﹤0.01% 4886
2024
Q3 		$16.8K Buy
271
+181
+201% +$12K ﹤0.01% 3760
2024
Q2 		$8.98K Buy
+90
New +$17.2K ﹤0.01% 3730

Other funds holding FBLG

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FEG
Fund Evaluation Group Cincinnati, Ohio $3.25B AUM 14.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM

BNP Paribas Financial Markets's FBLG Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its FibroBiologics (FBLG) stake by 1.5% in Q1 2026, buying an estimated $6 and bringing the position to 66 shares worth $87. The position accounts for ﹤0.01% of the portfolio, ranked #5691.

BNP Paribas Financial Markets first reported a position in FBLG in Q2 2024 and has held it in 8 quarters since. The position peaked at $16.8K in Q3 2024. 17 funds tracked by Wall St. Rank hold FBLG as of Q1 2026.

  • BNP Paribas Financial Markets held 66 shares of FibroBiologics worth $87 as of Q1 2026.
  • BNP Paribas Financial Markets bought 1 FibroBiologics share in Q1 2026, an estimated $6.
  • FibroBiologics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5691 holding.
  • BNP Paribas Financial Markets first reported a position in FibroBiologics in Q2 2024 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's FibroBiologics position peaked at $16.8K in Q3 2024.
  • 17 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.